Search research articles
Contact Us
Filters
Showing results (31-40 of 102) with videos related to
Page
of 11
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 17, 2024
Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis
Ellen O'Donnell, Allison Schuette, Michael Waltz, et al.
JAMA Neurology
|
October 5, 2017
Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction
Walter N Kernan, Catherine M Viscoli, Jennifer L Dearborn, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 20, 2020
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations
Angelo Ghezzi, Brenda Banwell, Amit Bar-Or, et al.
Multiple Sclerosis and Related Disorders
|
April 11, 2025
Childhood adversity in parents of patients with pediatric multiple sclerosis
Kimberly A O'Neill, Leigh Charvet, Allan George, et al.
Journal of Rehabilitation Research and Development
|
September 18, 2010
Prevalence, predictors, and outcomes of poststroke falls in acute hospital setting
Arlene A Schmid, Carolyn K Wells, John Concato, et al.
Journal of Comparative Effectiveness Research
|
March 6, 2013
Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process
Patricia A Deverka, Danielle C Lavallee, Priyanka J Desai, et al.
Diabetes Care
|
July 29, 2016
Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease
Silvio E Inzucchi, Catherine M Viscoli, Lawrence H Young, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 10, 2017
Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis
Carolyn E Schwartz, Stephanie A Grover, Victoria E Powell, et al.
Neurology
|
October 19, 2018
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US
Kristen M Krysko, Jennifer Graves, Mary Rensel, et al.
Neurology
|
December 20, 2015
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report
Tanuja Chitnis, Jayne Ness, Lauren Krupp, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 102) with videos related to
Sort By:
Page
of 11
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 17, 2024
Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis
Ellen O'Donnell, Allison Schuette, Michael Waltz, et al.
JAMA Neurology
|
October 5, 2017
Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction
Walter N Kernan, Catherine M Viscoli, Jennifer L Dearborn, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 20, 2020
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations
Angelo Ghezzi, Brenda Banwell, Amit Bar-Or, et al.
Multiple Sclerosis and Related Disorders
|
April 11, 2025
Childhood adversity in parents of patients with pediatric multiple sclerosis
Kimberly A O'Neill, Leigh Charvet, Allan George, et al.
Journal of Rehabilitation Research and Development
|
September 18, 2010
Prevalence, predictors, and outcomes of poststroke falls in acute hospital setting
Arlene A Schmid, Carolyn K Wells, John Concato, et al.
Journal of Comparative Effectiveness Research
|
March 6, 2013
Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process
Patricia A Deverka, Danielle C Lavallee, Priyanka J Desai, et al.
Diabetes Care
|
July 29, 2016
Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease
Silvio E Inzucchi, Catherine M Viscoli, Lawrence H Young, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 10, 2017
Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis
Carolyn E Schwartz, Stephanie A Grover, Victoria E Powell, et al.
Neurology
|
October 19, 2018
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US
Kristen M Krysko, Jennifer Graves, Mary Rensel, et al.
Neurology
|
December 20, 2015
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report
Tanuja Chitnis, Jayne Ness, Lauren Krupp, et al.
Page
of 11